Molecular Docking Analysis of Heparin–Diclofenac Complexes: Insights into Enhanced Cox Enzyme Inhibition for Pain Management

Manuel Ovidiu Amzoiu, Oana Taisescu, Emilia Amzoiu, Andrei Gresita, Georgeta Sofia Popescu, Gabriela Rău, Maria Viorica Ciocîlteu, Costel Valentin Manda, Marianna Mazza · 2025

Read Molecular Docking Analysis of Heparin–Diclofenac Complexes: Insights into Enhanced Cox Enzyme Inhibition for Pain Management by Manuel Ovidiu Amzoiu, Oana Taisescu, Emilia Amzoiu, Andrei Gresita, Georgeta Sofia Popescu, Gabriela Rău, Maria Viorica Ciocîlteu, Costel Valentin Manda, Marianna Mazza (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12734184.txt.

Description

Manuel Ovidiu Amzoiu leads a nine-author team modeling how heparin and diclofenac might team up against pain enzymes, in a paper from two thousand twenty-five. Diclofenac is a common anti-inflammatory drug that blocks COX enzymes. Heparin is known as an anticoagulant, and it also calms inflammation.

The study uses molecular docking and dynamics simulations. The team looked at each drug on its own, and at their pre-formed supramolecular complexes, against COX-1 and COX-2. Geometry and lipophilicity work rounded out the modeling. Pairing could change how they engage the target. The simulations probe if the complex inhibits the enzymes better than diclofenac alone. The results are predictions that wait for laboratory confirmation.

Catalog record

CREATORManuel Ovidiu Amzoiu, Oana Taisescu, Emilia Amzoiu, Andrei Gresita, Georgeta Sofia Popescu, Gabriela Rău, Maria Viorica Ciocîlteu, Costel Valentin Manda, Marianna Mazza
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12734184

Browse the full library · About the Tower of Babel